In addition to Wegovy, some providers may prescribe other semaglutides, Ozempic and Rybelsus, currently approved only for type 2 diabetes, for off-label use among those without diabetes or with low risk for cardiovascular complications
Below, we answer some of the most common questions about medication for losing weight, so you feel informed, confident, and ready to take a step toward your wellness goals
Which GLP-1 medications have shown cardiovascular benefits in clinical trials
Ye, M., Lin, W., Zheng, J
Find out if Ozempic is right for you or learn more about your treatment options when you schedule a telehealth visit to speak with one of our friendly staff members